Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

16.59
-0.8300-4.76%
Post-market: 16.590.00000.00%16:37 EDT
Volume:957.71K
Turnover:16.22M
Market Cap:739.28M
PE:-10.06
High:17.95
Open:17.60
Low:16.50
Close:17.42
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:24.29M
Volume Ratio:0.92
T/O Rate:3.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:2.88
PE(LYR):-9.17

Loading ...

Beta Bionics Chief Commercial Officer Mark Hopman Disposes of 36,870 Common Shares Worth $680,723.44

Reuters
·
1 hour ago

Beta Bionics CEO Sean Saint Disposes of 5,641 Common Shares for $113,261.01

Reuters
·
Sep 05

Beta Bionics Initiated at Market Perform by William Blair

Dow Jones
·
Aug 22

Beta Bionics price target raised to $18 from $15.50 at BofA

TIPRANKS
·
Aug 11

BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50

MT Newswires Live
·
Aug 11

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Beta Bionics price target lowered to $30.40 from $32 at Ladenburg

TIPRANKS
·
Jul 30

Analysts Are Bullish on Top NA Stocks: Waystar Holding Corp. (WAY), Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Jul 30

Beta Bionics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Beta Bionics Q2 FY26 Net Loss Widens 39% to $23.4 Million; Net Sales Climb 38% to $32 Million

Reuters
·
Jul 30

Beta Bionics reports Q2 EPS (53c), consensus (56c)

TIPRANKS
·
Jul 30

Beta Bionics backs FY26 revenue view $131M-$136M, consensus $133.48M

TIPRANKS
·
Jul 30

Beta Bionics Q2 Sales Beat Estimates on Pharmacy Channel Growth

Reuters
·
Jul 30

Beta Bionics Q2 EPS $(0.53) Beats $(0.56) Estimate, Sales $32.013M Beat $31.443M Estimate

Benzinga Earnings
·
Jul 30

Beta Bionics Inc Outlook FY Revenue USD 131-136 Million

THOMSON REUTERS
·
Jul 30

Beta Bionics Inc Q2 EPS USD -0.53

THOMSON REUTERS
·
Jul 30

Press Release: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Dow Jones
·
Jul 30

Beta Bionics Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Beta Bionics resumed with a Buy at UBS

TIPRANKS
·
Jul 28